XPost: alt.guitar.amps
From: BiteMe@Bitch.org

Merck Statement on Ivermectin use During the COVID-19 Pandemic

February 4, 2021 11:45 am ET

KENILWORTH, N.J., Feb. 4, 2021 – Merck (NYSE: MRK), known as MSD outside
the United States and Canada, today affirmed its position regarding use
of ivermectin during the COVID-19 pandemic. Company scientists continue
to carefully examine the findings of all available and emerging studies
of ivermectin for the treatment of COVID-19 for evidence of efficacy and safety. It is important to note that, to-date, our analysis has identified:

No scientific basis for a potential therapeutic effect against COVID-19
from pre-clinical studies;

No meaningful evidence for clinical activity or clinical efficacy in
patients with COVID-19 disease, and;
A concerning lack of safety data in the majority of studies.

We do not believe that the data available support the safety and
efficacy of ivermectin beyond the doses and populations indicated in the regulatory agency-approved prescribing information.

https://www.merck.com/news/...

--- SoupGate-Win32 v1.05
* Origin: you cannot sedate... all the things you hate (1:229/2)